skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i,
In your opinion, did CHR's recent quarterly report justify the significant drop in share price, and is there any sensible reason to think it might recover to at least where it was recently ($3.30 range) any time soon, or would you expect it to pretty much stay flat?
Sign me: wondering if I should have ignored the analysts who thought the name had legs and sold sooner.
Thanks.
Read Answer Asked by Peter on August 10, 2023
Q: What ails AEP ? It has had scandals and blunders many years ago, but I thought they were over all that. Morgan Stanley added AEP to it s Global Dividend Fund just last month. I bought AEP only days ago and its down over 10% ; down 5% in the past 5 days. Unusual for a boring utility. I don’t see news bad enough to warrant such a drop , but seems something there could be rotten. What gives? Are complete idiots running AEP? Regulatory issues? Heat melting the already weak management brains? What is going on under the hood? Would appreciate your deeper insight, many thanks
Read Answer Asked by Adam on August 10, 2023
Q: I hold some shares in Moderna and trying to find out what the future holds (2 yrs). They recently announced that their future COVID vaccine sales are expected to be above original projections, however the stock continues to come down. What is your view on this company as an investment going forward. Thank you.
Read Answer Asked by Francisco on August 10, 2023
Q: Hi 5i Team,

Are you able to provide an update on Eli Lilly which had a big move today? Would you continue to recommend it as a buy even after the price gain today?

Comparing it to Lantheus and Perion (very different industries and company size) which one do you feel more bullish on for a longer term hold?

Thanks as always,
Jon
Read Answer Asked by Jonathan on August 09, 2023
Q: Hello,

I would appreciate your thoughts on how the arrival of new diabetes/weight loss drugs (Ozempic, Wegovy and Mounjaro) might potentially impact the future revenues at Body Contour Centers? Could the advent of these new medications not have a significant potential impact on the existing players in the weight loss space?

Are you able to provide an estimate of what proportion of Alaris Equity Partners' existing annual income is attributable to their investment in Body Contour Centers?

Thank you!
Read Answer Asked by Richard on August 09, 2023
Q: Last week I bought some shares in BEPC, stock was up next day so I sold for a profit.
In my TD account they took back 10% of the sale, not the profit but the sale. When I contacted TD they said it was a withholding tax and that I will receive a T5013 for my 2023 taxes. So according to this rationale I sold at a profit but now have a loss. TD told me to contact Brookfield to clarify and I am now anticipating a "he said, she said" argument between these 2 groups. Is this something you have encountered before and if so can you advise on how to cut to the chase here.
Read Answer Asked by Steve on August 09, 2023